Stay updated on Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial

Sign up to get notified when there's something new on the Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Record History now includes Revision: v3.4.2 and removes Revision: v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-12T02:19:29.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The history now includes a new revision entry for v3.4.1 and removes v3.4.0, affecting only version-tracking metadata and not study details or user-facing content; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:30:12.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The Study Record Versions page now shows a glossary toggle, uses green and red highlights to denote additions and deletions, and updates the revision label to v3.4.0; capitalization for the No FEAR Act label was adjusted.
    Difference
    0.9%
    Check dated 2026-01-28T19:22:36.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The Record History shows a new revision entry (v3.3.4) and removes the prior revision (v3.3.3). This is a log-level update to the history and does not modify the study data.
    Difference
    0.1%
    Check dated 2026-01-14T04:10:56.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    A new revision entry Revision: v3.3.3 was added to the history. The HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed from the footer.
    Difference
    0.2%
    Check dated 2025-12-23T23:06:39.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    The page history shows an added revision (v3.3.2) and a removed revision (v3.2.0); this reflects a UI/system update with no substantive changes to the study record.
    Difference
    0.1%
    Check dated 2025-11-25T11:57:22.000Z thumbnail image

Stay in the know with updates to Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial page.